By Richard Hook2019-01-10T13:27:00
IPUT has secured a trio of new tenants for its redeveloped Earlsfort Terrace office scheme in Dublin taking a total of 40,000 sq ft between them.
In the lead letting, IPUT, alongside joint venture partner Cashel Fund, have let 26,000 sq ft of space to NASDAQ-listed US biotechnology company BioMarin Pharmaceuticals. The $2.8bn pharmaceutical giant, which is a global leader in enzyme replacement therapies (ERTs), will occupy the fourth, fifth and sixth floors of the city centre office building.
You must be logged in to continue
Register for free to finish this article
Registration includes the following benefits:
To access this article REGISTER NOW
Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.